These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11347237)

  • 1. Dynamic polyelectromyography, neurolysis, and chemodenervation with botulinum toxin A for assessment and treatment of gait dysfunction.
    Esquenazi A; Mayer NH; Keenan MA
    Adv Neurol; 2001; 87():321-31. PubMed ID: 11347237
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW; Cole LL; Liptak GS
    Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
    O'Brien CF
    Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of botulinum toxin type A on gait of children who are idiopathic toe-walkers.
    Brunt D; Woo R; Kim HD; Ko MS; Senesac C; Li S
    J Surg Orthop Adv; 2004; 13(3):149-55. PubMed ID: 15559690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B; Földy D; Hefter H; Auff E; Schnider P
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged vastus lateralis denervation after botulinum toxin type A injection.
    Dunne JW; Singer BJ; Silbert PL; Singer KP
    Mov Disord; 2010 Feb; 25(3):397-401. PubMed ID: 20108381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated feature assessment in instrumented gait analysis.
    Wolf S; Loose T; Schablowski M; Döderlein L; Rupp R; Gerner HJ; Bretthauer G; Mikut R
    Gait Posture; 2006 Apr; 23(3):331-8. PubMed ID: 15955701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin as a treatment for strabismus in systemic diseases].
    Moguel-Ancheita S; Dixon-Olvera S; Martínez-Oropeza S; Orozco-Gómez LP
    Arch Soc Esp Oftalmol; 2003 Jan; 78(1):9-14. PubMed ID: 12571768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A for the treatment of chronic anal fissure.
    Brisinda G; Cadeddu F; Mazzeo P; Maria G
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):219-28. PubMed ID: 19072412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin treatment of spastic cerebral palsy].
    Hansen LK; Pedersen NR; Westphall IT; Pedersen LT; Jensen H; Villads A
    Ugeskr Laeger; 2004 Aug; 166(34):2888-90. PubMed ID: 15449526
    [No Abstract]   [Full Text] [Related]  

  • 12. Two-plane injection of botulinum exotoxin A in glabellar frown lines.
    Ozsoy Z; Gözü A; Genç B
    Aesthetic Plast Surg; 2004; 28(2):114-5. PubMed ID: 15170246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease.
    Giladi N; Honigman S
    Mov Disord; 1997 Nov; 12(6):1085-6. PubMed ID: 9399243
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity.
    Elovic EP; Esquenazi A; Alter KE; Lin JL; Alfaro A; Kaelin DL
    PM R; 2009 Sep; 1(9):842-51. PubMed ID: 19769919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
    Glaser DA
    J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iatrogenic botulism in an amateur weight-lifter.
    Duffey P; Brown C
    Mov Disord; 2006 Jul; 21(7):1056. PubMed ID: 16639740
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromyotonia in a muscle flap producing a convulsing breast: successful treatment with botulinum toxin.
    Schwartz MS; Wren DR; Filshie J
    Mov Disord; 1998 Jan; 13(1):188-90. PubMed ID: 9452354
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
    Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.